Vascular KCNQ Potassium Channels as Novel Targets for the Control of Mesenteric Artery Constriction by Vasopressin, Based on Studies in Single Cells, Pressurized Arteries, and in Vivo Measurements of Mesenteric Vascular Resistance
- 13 February 2008
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 325 (2), 475-483
- https://doi.org/10.1124/jpet.107.135764
Abstract
Pressor effects of the vasoconstrictor hormone arginine vasopressin (AVP), observed when systemic AVP concentrations are less than 100 pM, are important for the physiological maintenance of blood pressure, and they are also the basis for therapeutic use of vasopressin to restore blood pressure in hypotensive patients. However, the mechanisms by which circulating AVP induces arterial constriction are unclear. We examined the novel hypothesis that KCNQ potassium channels mediate the physiological vasoconstrictor actions of AVP. Reverse transcriptase polymerase chain reaction revealed expression of KCNQ1, KCNQ4, and KCNQ5 in rat mesenteric artery smooth muscle cells (MASMCs). Whole-cell perforated patch recordings of voltage-sensitive K+ (Kv) currents in freshly isolated MASMCs revealed 1,3-dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2H-indol-2-one (linopirdine)- and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE-991)-sensitive KCNQ currents that were electrophysiologically and pharmacologically distinct from other Kv currents. Suppression of KCNQ currents by AVP (100 pM) was associated with significant membrane depolarization, and it was abolished by the protein kinase C (PKC) inhibitor calphostin C (250 nM). The KCNQ channel blocker linopirdine (10 μM) inhibited KCNQ currents in MASMCs, and it induced constriction of isolated rat mesenteric arteries. The vasoconstrictor responses were not additive when combined with 30 pM AVP, and they were prevented by the L-type Ca2+ channel blocker verapamil. Ethyl-N-[2-amino-6-(4-fluorophenylmethylamino)pyridin-3-yl] carbamic acid (flupirtine) significantly enhanced KCNQ currents, and it reversed constrictor responses to 30 pM AVP. In vivo, i.v. administration of linopirdine induced a dose-dependent increase in mesenteric artery resistance and blood pressure, whereas flupirtine had the opposite effects. We conclude that physiological concentrations of AVP induce mesenteric artery constriction via PKC-dependent suppression of KCNQ currents and L-type Ca2+ channel activation in MASMCs.Keywords
This publication has 51 references indexed in Scilit:
- Regulation of M(Kv7.2/7.3) channels in neurons by PIP2 and products of PIP2 hydrolysis: significance for receptor‐mediated inhibitionThe Journal of Physiology, 2007
- Molecular expression and pharmacological identification of a role for Kv7 channels in murine vascular reactivityBritish Journal of Pharmacology, 2007
- Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathwaysJournal of Applied Physiology, 2007
- Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Diverse mechanisms of antiepileptic drugs in the development pipelineEpilepsy Research, 2006
- Possible vascular role of increased plasma arginine vasopressin in congestive heart failureInternational Journal of Cardiology, 2006
- AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonistsNature Neuroscience, 2003
- Molecular Variants of KCNQ Channels Expressed in Murine Portal Vein MyocytesCirculation Research, 2003
- Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell lineBiochemical and Biophysical Research Communications, 1985
- Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake.Hypertension, 1981